Работы, на которые ссылается эта работа

Работ: 151

Работа: Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications

MicroRNA as a Potential Therapeutic Molecule in Cancer
Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn
Обзорная статья2022Цитирований: 5
ABI
Unique features of long non-coding RNA biogenesis and function
Jeffrey J. Quinn, Howard Y. Chang
Обзорная статья2015Цитирований: 4
ABI
miRNA: A Promising Therapeutic Target in Cancer
Amrutha Menon, Noraini Abd-Aziz, Kanwal Khalid +2
Обзорная статья2022Цитирований: 4
ABI
Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics
Takayuki Nojima, Nicholas Proudfoot
Обзорная статья2022Цитирований: 3
ABI
miR‐146a‐5p: Expression, regulation, and functions in cancer
Joseph R. Iacona, Carol S. Lutz
Обзорная статья2019Цитирований: 3
ABI
Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer
Shiva Najjary, Reza Mohammadzadeh, Ahad Mokhtarzadeh +3
Обзорная статья2020Цитирований: 3
ABI
The comprehensive landscape of miR-34a in cancer research
Sijing Li, Xiaohui Wei, Jinyong He +6
Обзорная статья2021Цитирований: 3
ABI
RETRACTED ARTICLE: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer
Jing Sun, Xin Cai, Mingo M. H. Yung +14
Статья2018Цитирований: 3
ABI
Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function
Junfeng Wang, Quanyi Wang, Yinan Guan +10
Статья2022Цитирований: 2
ABI
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
Maliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam +11
Обзорная статья2022Цитирований: 2
ABI
MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence
Malathi Ramalinga, Arpita Roy, Anvesha Srivastava +5
Статья2015Цитирований: 2
ABI
LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway
Qingqiang Dai, Tianqi Zhang, Jiaomeng Pan +1
Статья2020Цитирований: 2
ABI
EZH2: a novel target for cancer treatment
Ran Duan, Wenfang Du, Weijian Guo
Обзорная статья2020Цитирований: 2
ABI
Function of microRNA‑124 in the pathogenesis of cancer (Review)
Yuchen Liu, Yipin Yang, Xinyi Wang +9
Обзорная статья2023Цитирований: 2
ABI
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers
Ilaria Cavallari, Francesco Ciccarese, Evgeniya Sharova +5
Обзорная статья2021Цитирований: 2
ABI
Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM
Dejuan Kong, Elisabeth I. Heath, Wei Chen +13
Статья2012Цитирований: 2
ABI
ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1
Jun Zhang, Shuai Guo, Haiyan Piao +6
Статья2019Цитирований: 2
ABI
EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies
Ivana Samaržija, Marko Tomljanović, Renata Novak Kujundžić +1
Обзорная статья2022Цитирований: 2
ABI
Ezh2 Inhibition by Tazemetostat: Mechanisms of Action, Safety and Efficacy in Relapsed/refractory Follicular Lymphoma
Edith Julia, Gilles Salles
Статья2021Цитирований: 2
ABI
LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function
Yi Zhao, Changjiang Feng, Yunjing Li +2
Статья2019Цитирований: 2
ABI
Decoding hepatocarcinogenesis from a noncoding RNAs perspective
Mostafa K. Abd El‐Aziz, Alyaa Dawoud, Caroline Joseph Kiriacos +3
Обзорная статья2023Цитирований: 2
ABI
MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2
Juan Lü, Ming‐Liang He, Lu Wang +8
Статья2011Цитирований: 2
ABI
EZH2 couples pancreatic regeneration to neoplastic progression
Jon Mallen‐St. Clair, Rengin G. Soydaner-Azeloglu, Kyoung Eun Lee +7
Статья2012Цитирований: 2
ABI
Loss of <i>Ezh2</i> synergizes with <i>JAK2</i> -V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis
Takafumi Shimizu, Lucia Kubovčáková, Ronny Nienhold +11
Статья2016Цитирований: 2
ABI
Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target
Yiping Wen, Jing Cai, Yaya Hou +2
Обзорная статья2017Цитирований: 2
ABI